Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion type Assertion NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_head.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion description "[These findings suggest that (1) LB pathology can influence the clinical features of familial AD, (2) the E184D mutation of presenilin-1 may be associated with the LB formation through Abeta overproduction, although the process of LB formation is strongly affected by other unknown mechanisms, (3) in neurodegenerative disorders with LBs, there is a common pathophysiological background inducing NAC accumulation in neuritic plaques and astrocytes, and (4) the NAC accumulation in neuritic plaques is modulated by the abnormally aggregated tau protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_provenance.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion evidence source_evidence_literature NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_provenance.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion SIO_000772 12410385 NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_provenance.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion wasDerivedFrom befree-20140225 NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_provenance.
- NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_assertion wasGeneratedBy ECO_0000203 NP498935.RAgRw_o6XM5WKkuUAeXMaSVFd-Msd421ANwB57UaK21ag130_provenance.